APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $18M invested in Aptevo Therapeutics in 2017 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.32M
2
+$764K

Top Sellers

1
-$2.41M
2
-$948K
3
-$873K
4
Northern Trust
Northern Trust
Illinois
-$513K
5
Morgan Stanley
Morgan Stanley
New York
-$456K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$12K
52
$10K
53
$8.58K
54
$8K
55
$7K
56
$6K
57
$6K
58
$5K
59
$5K
60
$4K
61
$4K
62
$3K
63
$3K
64
$2K
65
$1.31K
66
$1K
67
$1K
68
$1K
69
$618
70
–
71
–
72
–
73
–
74
–
75
–
1 2
3
4